As for the early prediction of GDM, despite much progress in identifying novel GDM biomarkers including exosomes, microRNA, and plasma fatty acid-binding protein 4 (17–19), however, lack of the availability in clinical practice leads to their limited application. Here, FABP4 is linked to gestational diabetes.